LTS News & PR

NEWS & PR

LTS News & PR

NEWS & PR

All news and press releases

  • Dr. Mike Schaefers - new Chief Commercial Officer (CCO) at LTS
    May 1, 2022
    read more
  • We are flying the Ukrainian flag in front of our offices.
    March 3, 2022
    read more
  • LTS: new Chief Financial Officer
    January 1, 2022
    read more
  • PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, and LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, today announced they have entered into a process development agreement for the clinical trial scale up of PharmaTher’s proprietary Ketamine microneedle patch product.
    December 20, 2021
    read more
  • Beimei Pharma and LTS announce in-depth cooperation
    November 8, 2021
    read more
  • October 20, 2021
    read more
  • LTS expands research and development area for microneedles
    October 1, 2021
    read more
  • Positive results of the LTS ESKOT trial
    August 18, 2021
    read more
  • Welcome to our new apprentices
    August 2, 2021
    read more
  • EsoCap AG is a Swiss privately funded company based in Basle, Switzerland.
    June 25, 2021
    read more
  • Logo - Revive Therapeutics Ltd.
    May 17, 2021
    read more
  • LTS receives notice of allowance for U.S. patent related to Asenapine patch
    November 25, 2020
    read more
  • LTS: New research collaboration agreement for Micro Array Patches
    October 22, 2020
    read more
  • LTS presents Microarray Patches (MAP) at a virtual event
    October 16, 2020
    read more
  • LTS receives the “Highest Reputation” award
    August 17, 2020
    read more
  • LTS marketing campaign, a complete success - with award!
    July 20, 2020
    read more
  • New cooperation partner: Livzon Pharmaceutical Group Inc
    July 6, 2020
    read more
  • LTS Team Sebastian M. van Buijtenen, Chairman
    June 1, 2020
    read more
  • Completion of solar panel installation at LTS Corp. | LTS
    February 3, 2020
    read more
  • LTS Team - Dave Doles
    December 16, 2019
    read more